ALEXANDRA SHIGO: Open Payments
NPI 1780732867 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,661 in 100 payments from 19 companies in 2025. Trend: 2023 $2,036 · 2024 $2,721 · 2025 $2,661
Food & beverage: $2,562Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $339 |
| Novartis Pharmaceuticals Corporation | 9 | $288 |
| Janssen Biotech, Inc. | 7 | $265 |
| Botanix SB Inc | 7 | $232 |
| Galderma Laboratories, L.P. | 8 | $231 |
| GENZYME CORPORATION | 6 | $161 |
| Amgen Inc. | 7 | $159 |
| LEO Pharma Inc. | 5 | $136 |
| Incyte Corporation | 6 | $132 |
| Lilly USA, LLC | 5 | $124 |
Products named: SKYRIZI, TREMFYA, SOFDRA, NEMLUVIO, DUPIXENT, Rhapsido, OTEZLA, ADBRY.
Industry payments across FL — which companies pay providers there.
